App is temporarily unavailable
Description
服藥小幫手應用程式適用於使用口服Semaglutide的第二型糖尿病病人。
提醒您每日按時服用口服 Semaglutide建立新的常規，並以良好的方式開始治療 2 型糖尿病。 每天早上，您都會收到一條通知，幫助您建立自己關於服用口服 Semaglutide的良好習慣。
該應用程式的功能：
• 提醒您每天服用口服 Semaglutide
• 教導正確的服藥方式以獲得最佳治療效果
• 輕鬆獲取有關口服 Semaglutide的信息
• 記錄您今天是否服藥
該應用程式將為您提供用藥的提醒和指導，是幫助您在使用口服 Semaglutide治療初期時，可以快速上手的實用型應用程式!
經過30 天後，例行程序已成為您早上日常常態的一部分，您通常不再需要該應用程式。
如果您的醫師已為您處方口服 Semaglutide，請立即下載服藥小幫手App。
Show More...
提醒您每日按時服用口服 Semaglutide建立新的常規，並以良好的方式開始治療 2 型糖尿病。 每天早上，您都會收到一條通知，幫助您建立自己關於服用口服 Semaglutide的良好習慣。
該應用程式的功能：
• 提醒您每天服用口服 Semaglutide
• 教導正確的服藥方式以獲得最佳治療效果
• 輕鬆獲取有關口服 Semaglutide的信息
• 記錄您今天是否服藥
該應用程式將為您提供用藥的提醒和指導，是幫助您在使用口服 Semaglutide治療初期時，可以快速上手的實用型應用程式!
經過30 天後，例行程序已成為您早上日常常態的一部分，您通常不再需要該應用程式。
如果您的醫師已為您處方口服 Semaglutide，請立即下載服藥小幫手App。
Wake Up Routine FAQ
-
Is Wake Up Routine free?
Yes, Wake Up Routine is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Wake Up Routine legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
-
How much does Wake Up Routine cost?
Wake Up Routine is free.
-
What is Wake Up Routine revenue?
To get estimated revenue of Wake Up Routine app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
5 out of 5
3 ratings in Denmark
5 star
3
4 star
0
3 star
0
2 star
0
1 star
0
Ratings History
Wake Up Routine Reviews
服藥小幫手: 用藥提醒 Installs
Last 30 days
服藥小幫手: 用藥提醒 Revenue
Last 30 daysWake Up Routine Revenue and Downloads
Gain valuable insights into 服藥小幫手: 用藥提醒 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Novo Nordisk
- Languages
- Danish, Hungarian, Hindi, Gujarati, Tamil, Bengali, Kannada, German, Panjabi, Oriya, French, Telugu, Swedish, Chinese, Italian, English, Dutch, Arabic, Assamese, Marathi, Malayalam
- Recent release
- 1.8.7 (4 months ago )
- Released on
- Aug 13, 2020 (4 years ago )
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.